Company intelligence / Profile preview

North Carolina Clinical Research

Raleigh, North Carolina, United Statesnccr.com ↗

Ownership: Private
Development stage: Commercial

Overview

North Carolina Clinical Research is an independent outpatient clinical research site that has completed over 650 studies since its founding in 1986. The facility supports Phase I–IV trials across multiple therapeutic areas for both adult and pediatric populations. It is known for experienced staff and modern facilities but does not develop its own drugs or report proprietary clinical results.

Therapeutic areas: Metabolic DisordersPulmonologyImmunologyCardiovascularNeurology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Pharmaceutical companiesOther CROs

Beyond the preview

Go deeper on North Carolina Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on North Carolina Clinical Research.

Explore the full profile